Mitogen-Activated Protein Kinase 3
"Mitogen-Activated Protein Kinase 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS.
Descriptor ID |
D048052
|
MeSH Number(s) |
D08.811.913.696.620.682.700.567.249.750 D12.644.360.450.169.750 D12.776.476.450.169.750
|
Concept/Terms |
Mitogen-Activated Protein Kinase 3- Mitogen-Activated Protein Kinase 3
- Mitogen Activated Protein Kinase 3
- Meiosis-Activated Myelin Basic Protein Kinase p44(mpk)
- p44 MAPK
- Protein-Serine-Threonine Kinase p44(mpk)
- MAPK3 Mitogen-Activated Protein Kinase
- MAPK3 Mitogen Activated Protein Kinase
- Microtubule-Associated Protein-2 Kinase
- Kinase, Microtubule-Associated Protein-2
- Microtubule Associated Protein 2 Kinase
- ERK1 Kinase
- Kinase, ERK1
- PSTkinase p44mpk
- p44mpk, PSTkinase
- Extracellular Signal-Regulated Kinase 1
- Extracellular Signal Regulated Kinase 1
|
Below are MeSH descriptors whose meaning is more general than "Mitogen-Activated Protein Kinase 3".
Below are MeSH descriptors whose meaning is more specific than "Mitogen-Activated Protein Kinase 3".
This graph shows the total number of publications written about "Mitogen-Activated Protein Kinase 3" by people in this website by year, and whether "Mitogen-Activated Protein Kinase 3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 2 | 2 |
1997 | 0 | 4 | 4 |
1998 | 0 | 1 | 1 |
1999 | 0 | 3 | 3 |
2000 | 0 | 4 | 4 |
2001 | 0 | 3 | 3 |
2002 | 0 | 4 | 4 |
2003 | 0 | 4 | 4 |
2004 | 0 | 2 | 2 |
2005 | 0 | 2 | 2 |
2006 | 1 | 4 | 5 |
2007 | 0 | 1 | 1 |
2008 | 0 | 3 | 3 |
2009 | 1 | 2 | 3 |
2010 | 0 | 3 | 3 |
2011 | 0 | 2 | 2 |
2012 | 0 | 2 | 2 |
2013 | 1 | 3 | 4 |
2014 | 1 | 1 | 2 |
2015 | 2 | 1 | 3 |
2016 | 0 | 2 | 2 |
2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mitogen-Activated Protein Kinase 3" by people in Profiles.
-
IL-1ß Inhibits Connexin 43 and Disrupts Decidualization of Human Endometrial Stromal Cells Through ERK1/2 and p38 MAP Kinase. Endocrinology. 2017 12 01; 158(12):4270-4285.
-
Reversal of dendritic phenotypes in 16p11.2 microduplication mouse model neurons by pharmacological targeting of a network hub. Proc Natl Acad Sci U S A. 2016 07 26; 113(30):8520-5.
-
Constitutive Expression of a Dominant-Negative TGF-ß Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate. Circ Res. 2016 06 24; 119(1):69-82.
-
SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells. Oncotarget. 2015 Dec 22; 6(41):43162-71.
-
Cardioprotective Signature of Short-Term Caloric Restriction. PLoS One. 2015; 10(6):e0130658.
-
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2. J Med Chem. 2015 Feb 26; 58(4):1976-91.
-
Restoration of adiponectin expression via the ERK pathway in TNFa-treated 3T3-L1 adipocytes. Mol Med Rep. 2014 Aug; 10(2):905-10.
-
Paxillin mediates stretch-induced Rho signaling and endothelial permeability via assembly of paxillin-p42/44MAPK-GEF-H1 complex. FASEB J. 2014 Jul; 28(7):3249-60.
-
A novel p38 mitogen-activated protein kinase/Elk-1 transcription factor-dependent molecular mechanism underlying abnormal endothelial cell proliferation in plexogenic pulmonary arterial hypertension. J Biol Chem. 2013 Sep 06; 288(36):25701-25716.
-
Mice selectively bred for High and Low fear behavior show differences in the number of pMAPK (p44/42 ERK) expressing neurons in lateral amygdala following Pavlovian fear conditioning. Neurobiol Learn Mem. 2014 Jul; 112:195-203.